Stay updated with breaking news from 10x Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
10x Genomics (NASDAQ:TXG – Free Report) had its target price lowered by Canaccord Genuity Group from $65.00 to $50.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other equities analysts have also recently commented on TXG. Deutsche Bank Aktiengesellschaft decreased their price target […]
10x Genomics, Inc. (NASDAQ:TXG – Free Report) – William Blair lifted their Q2 2024 EPS estimates for 10x Genomics in a note issued to investors on Wednesday, May 1st. William Blair analyst M. Larew now anticipates that the company will post earnings per share of ($0.53) for the quarter, up from their prior forecast of […]
10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by The Goldman Sachs Group from $30.00 to $26.00 in a research report released on Wednesday, Benzinga reports. They currently have a sell rating on the stock. A number of other research firms also recently weighed in on TXG. TD Cowen downgraded shares of […]
The City of Pleasanton is turning 130 this year and reflecting on the stories that have graced the city since its founding. Officials are marking the milestone with a Concert
10x Genomics ( NASDAQ:TXG ) First Quarter 2024 Results Key Financial Results Revenue: US$141.0m (up 5.0% from 1Q 2023...